Supriya Lifescience Limited
Supriya Lifescience Limited (SUPRIYA.NS) Stock Overview
Explore Supriya Lifescience Limited’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
49.3B
P/E Ratio
26.60
EPS (TTM)
$23.02
ROE
0.19%
SUPRIYA.NS Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Supriya Lifescience Limited (SUPRIYA.NS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 50.44, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $763.56.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 26.60 and a market capitalization of 49.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.